摘要
目的：探讨微创经椎间孔腰椎间融合术治疗腰椎疾病临床效果。方法给予研究组微创经椎间孔腰椎间融合术，给予对照组传统开放经椎间孔椎体融合术。记录两组手术时间、术中出血量、术后住院时间、并发症发生情况及随访情况等，并进行统计学分析。结果研究组手术时间显著多于对照组，但研究组术中出血量、术后住院时间均显著少于对照组；研究组并发症发生率仅为20.00％，显著低于对照组并发症发生率45.00％；随访6个月两组视觉模拟评分（ VAS）较治疗前显著减少，而日本骨科协会评估治疗分数（ JOA）则较治疗前显著增加，与治疗前对比结果具有统计学意义（ P＜0.05），但两组对比P＞0.05，提示组间比较无统计学意义。结论对腰椎疾病患者给予微创经椎间孔腰椎间融合术治疗后可获得满意疗效及预后，利于患者尽快恢复健康，提高生活质量。
Abstract
Objective To explore the clinical effect of minimally invasive transforaminal lumbar interbody fusion surgery for lumbar disease . Methods The patients in research group were given the minimally invasive transforaminal lumbar interbody fusion surgery .The patients in the control group were given the traditional open transforaminal lumbar interbody fusion survey .The operative time , the quantity of bleeding during the surgery , the length of stay after the surgery , the occurrence of complication and the results of follow -up of the patients in the two groups were recorded .Statistical analysis was done .Results The operative time of the research group was longer than the control group , but the quantity of bleeding during the surgery and the length of stay after surgery of the research group were remarkably less than the control group.The complication rate of the research group was only 20.00%, which was significantly lower than the control group , in which the complication rate was 45.00%.During the six-month follow -up visit, it was found that VAS score of the two groups obviously reduced , but JOA score apparently increased .Compared with the treatment effect before the surgery , it was statistically significant ( P<0.05 ) .How-ever, with P>0.05, comparison of the two groups showed no statistical significance .Conclusion The patients with lumbar disease given transforaminal lumbar interbody fusion can obtain satisfactory treatment and prognosis .Minimally invasive transforaminal lumbar interbody fusion surgery helps the patients recover quickly and improve their life quality .
基金项目
揭阳市医学科学技术研究项目(揭市委［2014］60号)
NETL
NSTL
维普
万方数据